| MSD Merck Sharp & Dohme AG - Zostavax, Injektionssuspension | | 00709 | | 01 | | Zostavax | | Injektionssuspension | | J07BK02 | | Zoster, live attenuated | | 22.07.2007 | | |
| | Zusammensetzung | | Vaccinum attenuatum: virus varicellae vivus min. 19400 U., saccharum, gelatina hydrolysata, ureum, natrii chloridum, natrii hydrogenoglutamas monohydricus, dinatrii phosphas, kalii dihydrogenophosphas, kalii chloridum, neomycinum, pro vitro.
Solvens: aqua ad iniectabile. | | Packungsbestandteile | | Injektionssuspension | | | | | | Wirkstoffe | Stärke | Zusätzliche Information |
|---|
| Virus Varicellae Vivus | 19400 U | Vaccinum attenuatum |
| | | | Hilfsstoffe |
|---|
| Dinatrium Phosphat | | Gelatina Hydrolysata | | Kalium Chlorid | | Kalium Dihydrogenophosphat | | Natrium Chlorid | | Natrii Hydrogenoglutamas Monohydricus | | Neomycin | | Saccharum | | Ureum |
|
| Solvens | | aqua ad iniectabile | | | |
| Solvens | | aqua ad iniectabile | | | |
| Solvens | | aqua ad iniectabile | | | |
| Solvens | | aqua ad iniectabile | | | |
| Solvens | | aqua ad iniectabile | | | |
| Solvens | | aqua ad iniectabile | | | |
| | Packungsnummer | Packungsgrösse | EFP | PP | Kat. | SL | In Refdata nicht gelistet |
|---|
| 003 | Ampulle(n) | PA | PA | B | | Ja | | 004 | 10 Ampulle(n) | PA | PA | B | | Ja |
|
|
